Rene Quevedo, Ph.D.

2014-2020 Medical Biophysics University of Toronto, Toronto, ON, Canada 
"Rene Quevedo"


Sign in to add mentor
Trevor Pugh grad student 2014-2020
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Boukhaled GM, Gadalla R, Elsaesser HJ, et al. (2022) Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy. Nature Immunology
Hezaveh K, Shinde RS, Klötgen A, et al. (2022) Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 55: 324-340.e8
El Ghamrasni S, Quevedo R, Hawley J, et al. (2021) Mutations in Noncoding -Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer. Molecular Cancer Research : McR
Oldfield LE, Li T, Tone A, et al. (2020) An integrative DNA sequencing and methylation panel to assess mismatch repair deficiency. The Journal of Molecular Diagnostics : Jmd
Quevedo R, Smirnov P, Tkachuk D, et al. (2020) Assessment of Genetic Drift in Large Pharmacogenomic Studies. Cell Systems
Quevedo R, Spreafico A, Bruce J, et al. (2020) Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor. Genome Medicine. 12: 38
Loganathan SK, Schleicher K, Malik A, et al. (2020) Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling. Science (New York, N.Y.). 367: 1264-1269
Colombo I, Garg S, Danesh A, et al. (2019) Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a -mutated low-grade serous ovarian cancer patient. Cold Spring Harbor Molecular Case Studies. 5
Yang SYC, Lheureux S, Karakasis K, et al. (2018) Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors. Genome Medicine. 10: 81
Lheureux S, Bruce JP, Burnier JV, et al. (2017) Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016713677
See more...